These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 22543828

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Autologous peripheral blood stem cell transplantation for POEMS syndrome.
    Kuwabara S, Misawa S, Kanai K, Kikkawa Y, Nishimura M, Nakaseko C, Cho RK, Hattori T.
    Neurology; 2006 Jan 10; 66(1):105-7. PubMed ID: 16401856
    [Abstract] [Full Text] [Related]

  • 3. Combined submyeloablative and myeloablative dose intense melphalan results in satisfactory responses with acceptable toxicity in patients with multiple myeloma.
    Novitzky N, Thomson J, Thomas V, du Toit C, Mohamed Z, McDonald A.
    Biol Blood Marrow Transplant; 2010 Oct 10; 16(10):1402-10. PubMed ID: 20385248
    [Abstract] [Full Text] [Related]

  • 4. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
    Kuwabara S, Misawa S, Kanai K, Suzuki Y, Kikkawa Y, Sawai S, Hattori T, Nishimura M, Nakaseko C.
    Neurology; 2008 Nov 18; 71(21):1691-5. PubMed ID: 18832140
    [Abstract] [Full Text] [Related]

  • 5. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation.
    Sanada S, Ookawara S, Karube H, Shindo T, Goto T, Nakamichi T, Saito M, Matsubara M, Suzuki M.
    Am J Kidney Dis; 2006 Apr 18; 47(4):672-9. PubMed ID: 16564945
    [Abstract] [Full Text] [Related]

  • 6. Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome.
    Laurenti L, De Matteis S, Sabatelli M, Conte A, Chiusolo P, Sorà F, Piccirillo N, Za T, Tarnani M, Rossi E, Leone G, Sica S.
    Leuk Res; 2008 Aug 18; 32(8):1309-12. PubMed ID: 18207237
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
    Carreras E, Rosiñol L, Terol MJ, Alegre A, de Arriba F, García-Laraña J, Bello JL, García R, León A, Martínez R, Peñarrubia MJ, Poderós C, Ribas P, Ribera JM, San Miguel J, Bladé J, Lahuerta JJ, Spanish Myeloma Group/PETHEMA.
    Biol Blood Marrow Transplant; 2007 Dec 18; 13(12):1448-54. PubMed ID: 18022574
    [Abstract] [Full Text] [Related]

  • 9. New advances in the diagnosis and treatment of POEMS syndrome.
    Li J, Zhou DB.
    Br J Haematol; 2013 May 18; 161(3):303-15. PubMed ID: 23398538
    [Abstract] [Full Text] [Related]

  • 10. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
    Kastritis E, Terpos E, Anagnostopoulos A, Xilouri I, Dimopoulos MA.
    Clin Lymphoma Myeloma; 2006 Jul 18; 7(1):73-6. PubMed ID: 16879774
    [Abstract] [Full Text] [Related]

  • 11. Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
    Qazilbash MH, Saliba RM, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Flosser T, Couriel DR, De Lima M, Kebriaei P, Popat U, Alousi AM, Champlin RE, Giralt SA.
    Bone Marrow Transplant; 2007 Mar 18; 39(5):279-83. PubMed ID: 17262062
    [Abstract] [Full Text] [Related]

  • 12. [Successful treatment of POEMS syndrome with high-dose chemotherapy and autologous peripheral blood stem cell transplantation].
    Takai K, Niikuni K, Kurasaki T.
    Rinsho Ketsueki; 2004 Oct 18; 45(10):1111-4. PubMed ID: 15553046
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.
    Natl Med J India; 2003 Oct 18; 16(1):16-21. PubMed ID: 12715951
    [Abstract] [Full Text] [Related]

  • 15. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
    Perfetti V, Siena S, Palladini G, Bregni M, Di Nicola M, Obici L, Magni M, Brunetti L, Gianni AM, Merlini G.
    Haematologica; 2006 Dec 18; 91(12):1635-43. PubMed ID: 17145600
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
    Vannata B, Laurenti L, Chiusolo P, Sorà F, Balducci M, Sabatelli M, Luigetti M, Giannotta C, De Stefano V, Leone G, Sica S.
    Am J Hematol; 2012 Jun 18; 87(6):641-2. PubMed ID: 22488443
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor and POEMS.
    Dyck PJ, Engelstad J, Dispenzieri A.
    Neurology; 2006 Jan 10; 66(1):10-2. PubMed ID: 16401837
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment strategy for POEMS syndrome].
    Kawamura N, Kira J.
    Brain Nerve; 2008 Jun 10; 60(6):621-6. PubMed ID: 18567357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.